KEYVIBE-010: Adjuvant coformulated vibostolimab with pembrolizumab versus adjuvant pembrolizumab in patients with high-risk stage II-IV melanoma
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
adjuvant coformulated vibostolimab,adjuvant pembrolizumab,high-risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要